Formulation Development Solutions
-
Plug Into The Future Of Bispecific Antibodies
Lonza’s bYlok® technology is a true plug-and-play solution to bispecific antibody engineering – high product quality, simplified processes, unlocking the future.
-
A Fully Integrated Toolbox For Therapeutic Protein Expression
The GS Xceed® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.
-
Integrated Biotech Services: From Strain To Commercial Product
Backed by Lonza’s more than 30 years’ experience and expertise in biological processing and our track record in the chemical and biotechnological industry, we offer our customers a full “one-stop-shop” service package at all stages of development and production.
-
PBPK Predictive Modeling Services
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
-
Trusted End-To-End CDMO Partner For Your Journey
In an increasingly competitive environment, working with the right CDMO is vital for successful drug lifecycle management. We now serve more than half of the world’s leading biopharmaceutical companies, sharing their mission to expedite patient access to life-saving biologics.
-
Evolve The Future Of Cell Therapy Manufacturing
10/17/2022
Learn more about a closed, automated isolation and bead removal system for cell therapy manufacturing used to streamline and expedite your cell therapy development.
-
Solid Form Services
We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.
-
Adeno-Associated Virus (AAV) Manufacturing: A Scalable, Integrated Solutions Suspension Platform Approach
9/7/2022
Solutions for the challenges throughout the drug marketing journey – from development and manufacture, right through to the regulatory approval of AAV-based therapies.
-
4CellĀ® XtraCHO Media System
4/7/2021
The 4Cell® XtraCHO Media System is for protein production using CHO systems. Use of production media and feeding supplements helps satisfying cell culture requirement using different approaches conditions. Recommended protocols facilitate easy and efficient identification of a feeding strategy.
-
Mammalian Cell Culture: Process R&D Services
Lonza’s global R&D center for mammalian cell processes is based in Slough, UK alongside a custom manufacturing facility. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries. Read more about Lonza’s complete range of R&D Services and an array of technologies and skills to best match their customers’ requirements for all stages of product development.